Lucid Diagnostics (LUCD) Cash from Financing Activities (2021 - 2026)
Lucid Diagnostics filings provide 5 years of Cash from Financing Activities readings, the most recent being $2000.0 for Q4 2025.
- On a quarterly basis, Cash from Financing Activities fell 99.99% to $2000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $59.0 million, a 22.34% increase, with the full-year FY2025 number at $59.0 million, up 22.34% from a year prior.
- Cash from Financing Activities hit $2000.0 in Q4 2025 for Lucid Diagnostics, down from $27.1 million in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $64.3 million in Q4 2021 to a low of $1000.0 in Q4 2022.
- Median Cash from Financing Activities over the past 5 years was $4.7 million (2021), compared with a mean of $11.7 million.
- Biggest five-year swings in Cash from Financing Activities: tumbled 100.0% in 2022 and later surged 499900.0% in 2023.
- Lucid Diagnostics' Cash from Financing Activities stood at $64.3 million in 2021, then tumbled by 100.0% to $1000.0 in 2022, then surged by 499900.0% to $5.0 million in 2023, then soared by 259.98% to $18.0 million in 2024, then crashed by 99.99% to $2000.0 in 2025.
- The last three reported values for Cash from Financing Activities were $2000.0 (Q4 2025), $27.1 million (Q3 2025), and $16.5 million (Q2 2025) per Business Quant data.